Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. Here is part 2 of Endocrine News’s closer look at some of the endocrine science innovations announced throughout 2021. Endocrine researchers and clinicians continued to remain at the forefront of medical research, the result of which...
Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. From remarkable new treatments for acromegaly, thyroid eye disease, hypoglycemia, and diabetes to new devices aimed at glucose monitoring in adults and children, a mail-in semen analysis kit, and much more, Endocrine News takes a closer...
Postmenopausal Women May Benefit from Estrogen Compound Research
Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure. Hormone replacement therapy (HRT) is an effective treatment, but it carries increased risk of breast cancer, uterine cancers, and cardiovascular disease. Researchers...
HIV-1 Establishes “Sanctuary Site” In the Testis by Disrupting Blood-Testis Barrier Function
HIV-1, the most common type of human immunodeficiency virus, invades the testis and is able to avoid combination antiretroviral (cART) drugs by permeating the blood-testis barrier (BTB) and perturbing BTB function, potentially through the Tat protein, according to a study recently published in Endocrinology. Researchers led by C. Yan Cheng, PhD, senior scientist at The...
Researchers Roundtable: Talking to 2021 Early Investigator Award Winner, Ana Aulinas, MD, PhD
Each year the Endocrine Society recognizes endocrinologists who are in the early stages of their research careers by giving out the Early Investigator Awards. Endocrine News spoke to the five researchers from around the world to find out more about their award-winning research, the award’s potential impact, as well as how the COVID-19 pandemic has...
Study Examines Body-Composition Changes with Long-Term Pegvisomant Therapy of Acromegaly
Long-term pegvisomant therapy for acromegaly can lead to a sustained increase in adiposity but no change in skeletal muscle mass, according to a study recently published in Journal of the Endocrine Society. Researchers led by Pamela U. Freda, MD, of the Columbia University Department of Medicine in New York, point out that pegvisomant, a growth...
Gut Instincts: The Endocrinologists Behind the 2020 Warren Alpert Foundation Prize
Endocrine Society members Daniel J. Drucker, MD, and Joel F. Habener, MA, MD, talk to Endocrine News about their 2020 Warren Alpert Foundation Prize-winning research of key intestinal hormones, as well as their distinguished careers and what this award means to them. On October 1, the Warren Alpert Foundation Prize will be presented in a...
When the world was thrown into disarray earlier this year due to the COVID-19 pandemic, ENDO 2020 in San Francisco was one of the many casualties. All was not lost, however, as the Endocrine Society quickly regrouped and rebounded and hosted the all new, completely virtual ENDO Online 2020 taking place over two weeks in...